chrisvoncsefalvay/vaers-outcomes huggingface dataset:
caller states she developed Bell's Palsy specifically after the second dose of the Pfizer BioNTech Covid-19 vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Manufacturer Unknown, Dose 1), for COVID-19 Immunization. The following information was reported: BELL'S PALSY (medically significant), outcome "unknown", described as "caller states she developed Bell's Palsy specifically after the second dose of the Pfizer BioNTech Covid-19 vaccine".  The lot number for bnt162b2 was not provided and will be requested during follow up.
Pt received the vaccine 1/29/21 at 3pm.  Started developing symptoms of covid-19 (fever, chills) on 1/31/21.  Diagnosed with covid-19 at PCP office on 2/3/21 - did not received any treatment at that time.  Pt informed the pharmacy about this on 2/8/21
Too sleepy all the time, it's difficult to handle it/ spend the day being very sleepy.; To wake up is very difficult, during the day; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7484) via an unspecified route of administration in the right arm on 29Aug2021 at 13:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EY0580) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. On 03Sep2021 at 13:00, the patient felt too sleepy all the time and it was difficult for the patient to handle it. It was very difficult for the patient to wake up during the day and spent the day being very sleepy. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events too sleepy all the time, it was difficult for the patient to handle it/spend the day being very sleepy and to wake up is very difficult, during the day was not resolved at the time of this report.
3 vaccines / I still get shingles/suspected vaccination failure; I still get shingles; 3 vaccines / I still get shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 3rd dose of Shingles vaccine, the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and extra dose administered. On an unknown date, the outcome of the vaccination failure, shingles and extra dose administered were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine, Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient received 3 dose of Shingles vaccine, which led to extra dose administered. The patient stated that 3 vaccines for 300 dollars and still got the shingles. This case was considered as suspected vaccination failure as details regarding, time to onset and laboratory confirmation were unknown at the time of reporting.
low grade fever (100); general malaise; This is a spontaneous report from a non-contactable consumer (patient). This 62-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EL3248) via an unspecified route of administration in the left arm on 19Feb2021 at 13:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 24Feb2021 the patient experienced a low-grade fever (100) and general malaise. The events were reported as non-serious and did not require hospitalization. No treatment was provided for the events. Lab tests included body temperature of 100. The clinical outcomes of low-grade fever (100) and general malaise were unknown. It was also reported the patient had not been tested for COVID-19 since vaccination.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a physician assistant refers to a 4 year old patient of unknown gender. Drug reactions or allergies and pertinent medical history were unspecified. On 19-APR-2014, the 4 year old patient was vaccinated with ROTATEQ dose 1, 2ml, oral (strength and lot number were not reported). The reporter also stated that the second dose of ROTATEQ was administered in approximately June 2014 (reported as about 8-9 weeks later after the first dose). Concomitant therapies were unspecified. No adverse effect reported.  The outcome of the 4 year old patient receiving the first dose of ROTATEQ was unknown. The action taken with ROTATEQ was unknown. Additional information has been requested.
5pm T of 104 /p napping-started acting "dopey"-would fall to side while sitting up & not responsive as nl. 7pm seen in ER & was told immun. rxn. Felt warm the following day but much improved. The only TX was Tylenol q4 hrs
Information has been received from a registered nurse concerning her 16 year old daughter with headaches who on an unspecified date was vaccinated with a second dose of GARDASIL. Concomitant therapy included influenza virus vaccine (unspecified) on an unspecified date. Subsequently 24 hours after receiving the second dose of GARDASIL the patient experienced dizziness that lead to a headache. Medical attention was sought. At the time of reporting the patient had recovered. No further information was provided. Additional information has been requested. 02/17/2010 Subsequently on 04-DEC-2007 at 8 AM, 12 hours after receiving the second dose of GARDASIL the patient experienced dizziness (severe-could not stand up) severe headache, lightheadedness, no nausea and no fever. Medical attention was sought. "Did not take to hospital-thought was a virus going around". On 07-DEC-2008 the patient had recovered. No further information was provided. Additional information is not expected.
The vaccine was administered and almost immediately a warm sensation like a "flush" occurred throughout my body. Began to feel unusual and then the heart began to race. Paramedics notified and blood pressure elevated
Narrative: COVID infection following completion of COVID vaccine series 03/10/21 COVID vaccine dose #1 03/31/21 COVID vaccine dose #2 04/03/21 Pt resents to ED reporting cough, chest tightness, and difficulty breathing that started 04/02; CXR normal; discharged home with rx for medrol, albuterol/ipratropium, benzonatate for bronchial hyperreactivity; COVID NEGATIVE 05/13/21 Pt presents to clinic reporting symptoms of bronchial hyperreactivity has resolved 08/02/21 Pt presents to screening reporting cough, headache, and runny nose x1 day (08/01); COVID POSITIVE 08/03/21 Pt reports moderate cough, mild diarrhea, moderate fatigue, headache, runny nose, SOB, mild sore throat; rx given for benzonatate 08/06/21 Pt reports loss of taste/smell, sore throat. SOB with exertion, and improving cough, fatigue, and headache 08/07/21 Pt reports very mild cough and improving fatigue 08/12/21 Pt is clinically resolved
Pt. rec'd pneumo shot 1:00PM #1. Next day at 3AM woke with rash & swollen hands. Went to ER who gave IV BENADRYL and PEPCID per pt.
I've been waiting to hear from someone that has gotten it after the shot/suspected vaccination failure; I've been waiting to hear from someone that has gotten it after the shot.; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The patient had been waiting to hear from someone that has gotten it after the shot. The patient got the Shingles vaccine and got the shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. This case has been linked with the case US2021AMR184527, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR184527:same reporter
Dysesthesia affecting both sides of body. ED visit to hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
hard to walk; legs hurts; muscles aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 86 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: GAIT DISTURBANCE (non-serious), outcome "unknown", described as "hard to walk"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "legs hurts"; MYALGIA (non-serious), outcome "unknown", described as "muscles aches".  Additional Information: Took last shot of Pfizer today.  Anybody complain about muscle aches in legs? Has lower back problems.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I had an adverse reaction 10 minutes after my injection.  My heart rate went up as well as my BP, I felt hot and faint. Ems was on site and monitored until ambulance arrived. I was given Benadryl immediately.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On 19-MAY-2013 the patient was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (lot # J000494, exp. date: 14-APR-2014) as doctor recommendation. Concomitant medication included "couple of medications". It was reported that patient received ZOSTAVAX and 1-2 days after vaccination on approximately 20-MAY-2013 the patient experienced itchy and redness at the injection site. The patient was given topical CORTAID for the events. At the time of report, the patient was recovering from the events. Additional information is not expected.
Myocarditis; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 16 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02May2021 (Lot number: EW0162) at the age of 16 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing) and no other medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (previous COVID-19 vaccine product also Pfizer product and lot number is ER8730, dose1, administrated in the left arm), administration date: 11Apr2021, when the patient was 16 years old, for Covid-19 Immunization. The following information was reported: MYOCARDITIS (hospitalization, disability, life threatening) with onset 31Jul2021 06:00, outcome "not recovered", described as "Myocarditis". The patient was hospitalized for myocarditis (hospitalization duration: 3 day(s)). The event "myocarditis" was evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test (Nasal Swab): (31Jul2021) negative. Therapeutic measures were taken as a result of myocarditis included Ibuprofen.
This spontaneous report as received from a healthcare worker refers to a 25 year old patient of unknown gender. On 10-AUG-2015 and 13-OCT-2015, the patient was vaccinated with a dose of improperly stored GARDASIL (Lot # L010596, expiration date; 06-APR-2017) (strength, dose and route were not provided). No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
Patient Did not present to nurse with proof of vaccination. Self-attested to native language speaking nurse and certified translator that she had only had one dose of COVID-19 vaccine. Because primary dose was to be documented on a form, when we logged into the state vaccine registry, we discovered that she had had 3 monovalent Pfizer shots with the last one being recorded on 09/28/2022. She was not yet eligible to receive the bivalent booster, and received a 4th monovalent dose.
experiencing adverse effect from my 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (experiencing adverse effect from my 2nd dose) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (experiencing adverse effect from my 2nd dose). At the time of the report, VACCINATION COMPLICATION (experiencing adverse effect from my 2nd dose) outcome was unknown.            Concomitant information use was not reported.  Treatment information was not provided.   This case was linked to MOD-2021-036787 (Patient Link).
Blood pressure 50/40 heart beat 50 fever  body spasms eye spasms diarrhea short breath lot headaches skin burning when showering skin very dry and swollen
Site red and swollen, arm felt funny, felt feverish and achy. No visit to clinic for treatment.
I got the shingles shot twice. Both times I got the shingles/ suspected vaccination failure; Got them twice after the shots/ got the shingles; This case was reported by a consumer via (Facebook) interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got the shingles shot twice and both times got the shingles. The reporter stated that, shingles were one of the many side effets from the covid shot and this was the reason why the patient's doctor advised not to take the covid shot. This case was considered as suspected vaccination failure as details regarding the laboratory test confiding shingles and time to onset for shingles were unknown at the time of reporting. This case is linked with the case- US2021AMR139339, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR139339:Same reporter
Pt woke up next am with swollen leg where DTaP was given. Limping on leg. Mom put cold packs and gave Tylenol. After 1 hour pt was playing- walking okay swelling decreased.
I have had a headache every single day since the shot. It?s manageable but it?s annoying and will start hurting real bad right before I go to bed. Only way it will stop is if I will take 4 ibuprofen. I can?t take that many every single day.
The vaccine was administered too high on the shoulder and not into the deltoid muscle. Pt noted that the needle hit "something" during administration. She had soreness immediately - beyond the usual level of vaccine administration. She has given ample time for  healing but soreness and mobility issues persist in that shoulder. She specifically has difficulty in raising the arm and it causes her difficulty in performing work functions. She has not yet visited a doctor regarding this as she is a young person and concerned about the cost of therapy.
Scratchy throat, feels like throat closing up, coughing to clear airway. Voice hoarse and feels like she is having anaphylaxis as she has had in past
This spontaneous report was received from a pharmacist refers to a 55 years old female patient. On 05-AUG-2013 the patient was vaccinated with a 0.65ml dose of ZOSTAVAX (lot# H021292, expiration date: 23-FEB-2014), subcutaneous at unspecified location. Concomitant therapies included with CYMBALTA, SINGULAIR, hydrochlorothiazide, XANAX, prednisone, PEPCID, NEURONTIN, trazodone hydrochloride, albuterol, DUONEB, PERCOCET and metoprolol. The pharmacist reported that patient received ZOSTAVAX and had an injection site reaction that was swollen and "half dollar size" that was also "hot to the touch" on an unspecified date. The patient had sought medical attention via pharmacy visit. None lab diagnostics studies was performed. No treatment was given. At the time of report, the outcome was not recovered. Additional information has been requested.
Crazy amounts of bruising for no reason on my upper right thigh, left thigh and edge of my knee (this one is almost 2 inches in length)
Mom states the evening after receiving immunizations that child was walking different and off balance. She denies pain in either leg. No redness or induration either.
burning/pain/tingling to face/lips and mild chest tightness, onset 15 min after vaccination.  Burning/pain/tingling to face lasted approx. 50min, mild chest tightness lasted approx. 30 min
Injection site warmth, swelling, redness, and pain for at least 2 days after vaccination. Apparent full resolution. Patient was 29.4 weeks pregnant at time of vaccination. Patient also had some systemic symptoms, including fever (100.4 F), tachycardia (120 bpm), and fatigue. These may have been early symptoms of an upper respiratory infection that was diagnosed a few days later rather than related to the vaccine reaction.
dyspnea, shortness of breath, unable to speak long sentences without a cough presenting, quickened heartbeat, exhaustion, slept 13.45 hours straight
vaccinate site red and swollen x 1 day, diagnosed with cellulitis. Treated with a 7 day course of amoxicillin
injection site supposed to itch; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (injection site supposed to itch) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (injection site supposed to itch). At the time of the report, VACCINATION SITE PRURITUS (injection site supposed to itch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported , No treatment medication was reported .
Vertigo; dizzy; temp was up to 99.6; chills; arm was swollen; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm  was swollen), VERTIGO (Vertigo), DIZZINESS (dizzy), PYREXIA (temp was up to 99.6) and CHILLS (chills) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PERIPHERAL SWELLING (arm  was swollen), DIZZINESS (dizzy), PYREXIA (temp was up to 99.6) and CHILLS (chills). On an unknown date, the patient experienced VERTIGO (Vertigo). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (arm  was swollen), VERTIGO (Vertigo), DIZZINESS (dizzy), PYREXIA (temp was up to 99.6) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, Body temperature: 99.6 (High) (99.6).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Left anterior thigh 7.5cm length redness + 2 with underlying hardness at tip.  4.0cm width.  Warm to touch.  Sm pimples present.  Instructed parent to apply cool compressor x 10 min 2 x day, and return for rev within 3 days.
pt devel enlarged lymph nodes the day following vax;node smaller but still palpable;
Slight headache; sore throat; This is a spontaneous report from a contactable consumer. A 61-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EK5730/expiration date unknown) dose number 1 via an unspecified route of administration on the left arm on 18Dec2020 11:15 for COVID-19 immunization. Medical history included polycythemia vera, high BP, and GERD (gastrooesophageal reflux disease). Concomitant medications included omeprazole, aspirin [acetylsalicylic acid], hydroxyurea, tapentadol hydrochloride (NUCYNTA), and amlodipine besilate (NORVASC). The patient experienced slight headache and sore throat on 18Dec2020 12:15. The outcome of the events was not recovered.
My right arm was swollen and in a lot of pain, my stomach hurt, and I started to get very itchy. I was lethargic and had no energy. I went to the Urgent Care listed above, and I was given a steroid shot. However, I was diagnosed with a double ear infection and pneumonia after complaining of chest pain. I made a Teledoc appointment, and they couldn't decipher if I had Covid or a reaction from the vaccine.
Had flu shot on 11/2/18, and initially thought I had normal post-shot pain, but eventually began to worsen and has yet to go away. Shot felt normal when administered. Constant pain in left shoulder, worsens with movement. Very limited range of motion and arm is weak. Is particularly bad in the evening, through to morning. Causes discomfort during sleep, as well. Sometimes tingling goes to elbow and palm of hand.
pt c/o L chest pain/pressure after receiving moderna vaccine pt received vaccine after 1743. Pulse was 102 rapid on R arm. Pt was observed for 30 minutes, pt declined further medical intervention. 1824 pt was driven home by husband. no further interventions required.